FDA Approved: FYCOMPA — Supplemental Application (Eisai Inc.)

View source ↗

Summary

FDA approved Eisai's supplemental application for FYCOMPA (perampanel) to update the labeling and potentially expand its approved uses for epilepsy. The action …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lennox-gastaut Syndrome
• Partial-onset Seizures

Drugs mentioned

• Fycompa (perampanel)

Snippet

SUPPL AP for FYCOMPA (PERAMPANEL)